CEP Magazine

Profile: Innovating Plant-Based Vaccines and Therapeutics

April
2017
Profile
“Bringing a new product to market is never an easy task,” says Marc-André D’Aoust, Vice President, Research and Innovation, of Medicago. “At Medicago, we’re developing new products, such as influenza virus-like particles (VLPs), manufactured in a...